Corona Corporation (TYO:5909)
Japan · Delayed Price · Currency is JPY 975.00
+9.00 (0.93%)
Aug 4, 2026, 3:30 PM JST
Corona Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 85,376 | 85,338 | 85,214 | 82,046 | 85,335 | 78,648 | |
Revenue Growth | 0.14% | 0.15% | 3.86% | -3.85% | 8.50% | -4.29% |
Cost of Revenue | 66,950 | 66,975 | 66,823 | 64,005 | 66,577 | 61,249 |
Gross Profit | 18,426 | 18,363 | 18,391 | 18,041 | 18,758 | 17,399 |
Selling, General & Admin | 16,508 | 16,533 | 16,117 | 15,714 | 15,885 | 15,653 |
Research & Development | 696 | 696 | 644 | 669 | 653 | 632 |
Other Operating Expenses | 271 | 271 | 287 | 298 | 323 | 266 |
Operating Expenses | 17,485 | 17,510 | 17,047 | 16,685 | 16,856 | 16,548 |
Operating Income | 941 | 853 | 1,344 | 1,356 | 1,902 | 851 |
Interest Expense | -10 | -8 | -5 | -3 | -3 | -3 |
Interest & Investment Income | 359 | 344 | 267 | 259 | 246 | 218 |
Earnings From Equity Investments | 28 | 31 | 23 | 25 | 51 | 33 |
Currency Exchange Gain (Loss) | -2 | -2 | -1 | -7 | - | -3 |
Other Non Operating Income (Expenses) | 100 | 98 | 91 | 131 | 85 | 80 |
EBT Excluding Unusual Items | 1,416 | 1,316 | 1,719 | 1,761 | 2,281 | 1,176 |
Gain (Loss) on Sale of Investments | 5 | 8 | -16 | 57 | 9 | 32 |
Gain (Loss) on Sale of Assets | 3 | 3 | 6 | 5 | 5 | 4 |
Asset Writedown | -8 | -8 | -9 | -26 | -7 | -12 |
Legal Settlements | - | - | - | - | -167 | - |
Other Unusual Items | - | - | - | 1 | 1 | -1 |
Pretax Income | 1,416 | 1,319 | 1,700 | 1,798 | 2,122 | 1,199 |
Income Tax Expense | 342 | 328 | 597 | 492 | 640 | 260 |
Net Income | 1,074 | 991 | 1,103 | 1,306 | 1,482 | 939 |
Net Income to Common | 1,074 | 991 | 1,103 | 1,306 | 1,482 | 939 |
Net Income Growth | 41.50% | -10.15% | -15.54% | -11.88% | 57.83% | 50.00% |
Shares Outstanding (Basic) | 29 | 29 | 29 | 29 | 29 | 29 |
Shares Outstanding (Diluted) | 29 | 29 | 29 | 29 | 29 | 29 |
Shares Change | 0.12% | 0.12% | 0.02% | 0.09% | 0.16% | -0.19% |
EPS (Basic) | 36.73 | 33.90 | 37.77 | 44.74 | 50.81 | 32.25 |
EPS (Diluted) | 36.73 | 33.90 | 37.77 | 44.74 | 50.81 | 32.25 |
EPS Growth | 41.33% | -10.26% | -15.56% | -11.96% | 57.57% | 50.29% |
Free Cash Flow | - | -3,212 | -1,693 | -1,968 | 2,581 | 2,504 |
Free Cash Flow Per Share | - | -109.87 | -57.98 | -67.41 | 88.49 | 85.99 |
Dividend Per Share | 28.000 | 28.000 | 28.000 | 28.000 | 28.000 | 28.000 |
Dividend Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Gross Margin | 21.58% | 21.52% | 21.58% | 21.99% | 21.98% | 22.12% |
Operating Margin | 1.10% | 1.00% | 1.58% | 1.65% | 2.23% | 1.08% |
Profit Margin | 1.26% | 1.16% | 1.29% | 1.59% | 1.74% | 1.19% |
Free Cash Flow Margin | - | -3.76% | -1.99% | -2.40% | 3.02% | 3.18% |
EBITDA | 3,126 | 2,921 | 2,945 | 3,548 | 3,659 | 2,942 |
EBITDA Margin | 3.66% | 3.42% | 3.46% | 4.32% | 4.29% | 3.74% |
D&A For EBITDA | 2,185 | 2,068 | 1,601 | 2,192 | 1,757 | 2,091 |
EBIT | 941 | 853 | 1,344 | 1,356 | 1,902 | 851 |
EBIT Margin | 1.10% | 1.00% | 1.58% | 1.65% | 2.23% | 1.08% |
Effective Tax Rate | 24.15% | 24.87% | 35.12% | 27.36% | 30.16% | 21.68% |
Advertising Expenses | - | 1,338 | 1,354 | 1,250 | 1,204 | 1,059 |